Lanean...
Biomarker Use for Dementia with Lewy Body Diagnosis: Survey of U.S. Experts
BACKGROUND: Dementia with Lewy body (DLB) diagnostic criteria define “indicative” and “supportive” biomarkers, but clinical practice patterns are unknown. METHODS: An anonymous survey querying clinical use of diagnostic tests/biomarkers was sent to 38 center of excellence investigators. The survey i...
Gorde:
| Argitaratua izan da: | Alzheimer Dis Assoc Disord |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904569/ https://ncbi.nlm.nih.gov/pubmed/33009039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000414 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|